Medications

Gilead's Harvoni accepted in Canadian health plan

Gilead Sciences said multiple Canadian provinces will provide access to the biotechnology company's hepatitis C drug Harvoni following a positive reimbursement recommendation from regulators.

Medications

FDA warns 17 companies about illegal Alzheimer disease products

(HealthDay)—A number of warning/advisory letters have been issued to 17 companies for selling illegal products that claim to prevent, treat, or cure Alzheimer disease and other serious conditions, the U.S. Food and Drug ...

Diseases, Conditions, Syndromes

US working with drug firm on new coronavirus treatment

The United States is working with a pharmaceutical company to develop a treatment for the 2019 Novel Coronavirus, using a class of drug that has boosted survival rates among Ebola patients, officials said Tuesday.

page 23 from 40